Anastrozole, marketed under the brand name Arimidex, is a non-steroidal aromatase inhibitor used primarily in the treatment of breast cancer in postmenopausal women. This medication works by reducing the production of estrogen in the body, which can slow or stop the growth of certain types of breast tumors that rely on estrogen to grow.
Developed in the 1990s, anastrozole received FDA approval in 1995 and has since become a cornerstone in hormone therapy for breast cancer. Its mechanism of action involves selectively inhibiting the aromatase enzyme, which is responsible for converting androgens into estrogens. By blocking this conversion, anastrozole effectively lowers circulating estrogen levels, particularly in postmenopausal women where the ovaries are no longer the primary source of estrogen.
Anastrozole is typically prescribed as a 1 mg tablet taken once daily, with or without food. It's used in various breast cancer scenarios, including as adjuvant therapy for early-stage hormone receptor-positive breast cancer, as first-line treatment for advanced or metastatic breast cancer, and in cases where the cancer has progressed despite tamoxifen therapy.
While effective, anastrozole can cause side effects such as hot flashes, joint pain, weakness, mood changes, and an increased risk of osteoporosis. It's important to note that this medication is not suitable for premenopausal women or during pregnancy due to its mechanism of action and potential fetal harm.
The introduction of anastrozole and other aromatase inhibitors has significantly improved the treatment landscape for postmenopausal breast cancer patients. These drugs often show better efficacy and a more favorable side effect profile compared to older treatments like tamoxifen, particularly in terms of reducing the risk of cancer recurrence and improving overall survival rates in eligible patients.
https://www.hormonerawsource.com/steroid-finished-us-domestic-shipping/steroid-finished-tablets-3-days-to-arrive/fierce-anastrozole-arimidex-tablets.html
